Repare Therapeutics Inc.

NasdaqGS:RPTX Stock Report

Market Cap: US$114.2m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Repare Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:RPTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Nov 25SellUS$5,422,267Versant Venture Management, LLCCompany2,561,957US$2.16
13 Mar 25SellUS$24,144Lloyd SegalIndividual21,179US$1.14
13 Mar 25SellUS$6,397Michael ZindaIndividual5,611US$1.14
13 Mar 25SellUS$4,099Maria KoehlerIndividual3,596US$1.14
13 Mar 25SellUS$4,331Philip HermanIndividual3,799US$1.14
13 Mar 25SellUS$2,037Daniel BelangerIndividual1,787US$1.14

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RPTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders210,8790.489%
VC/PE Firms6,766,14715.7%
Hedge Funds10,333,60024%
Institutions11,961,01727.7%
General Public13,836,71932.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 67.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24%
BVF Partners L.P.
10,333,600US$27.4m0%0.73%
7.99%
CHI Advisors LLC
3,443,659US$9.1m0%4.43%
7.82%
Blue Owl Capital Holdings LP
3,372,499US$8.9m0%no data
7.71%
OrbiMed Advisors LLC
3,322,488US$8.8m0%0.11%
4.5%
MPM BioImpact LLC
1,941,242US$5.1m0%0.46%
3.68%
Redmile Group, LLC
1,586,174US$4.2m0%0.25%
1.9%
BioImpact Capital LLC
819,924US$2.2m0%72.82%
1.68%
Renaissance Technologies LLC
724,160US$1.9m38.5%no data
1.62%
Citadel Advisors LLC
699,297US$1.9m-25.4%no data
1.5%
Rangeley Capital, LLC
645,876US$1.7m81.8%1.26%
1.32%
Acadian Asset Management LLC
568,301US$1.5m-16.6%no data
0.61%
Northern Trust Global Investments
262,201US$694.8k-8.32%no data
0.46%
Affinity Asset Advisors, LLC
200,000US$530.0k0%0.04%
0.34%
BlackRock, Inc.
146,550US$388.4k0%no data
0.29%
David Bonita
124,400US$329.7k0%no data
0.28%
Militia Capital Management, LLC
119,176US$315.8k0%0.13%
0.24%
BMO Asset Management Corp.
104,919US$278.0k0%no data
0.21%
Abaris Investment Management AG
92,500US$245.1k0%0.23%
0.2%
Versant Venture Management, LLC
84,700US$224.5k-96.8%0.1%
0.18%
Stifel Asset Management Corp.
77,600US$205.6k-3.72%no data
0.15%
Squarepoint OPS LLC
65,243US$172.9k0%no data
0.11%
XTX Markets Limited
47,547US$126.0k10.1%0.01%
0.093%
Vontobel Asset Management, Inc.
40,000US$106.0k0%no data
0.093%
Quinn Opportunity Partners LLC
40,000US$106.0k0%0.01%
0.089%
IEQ Capital, LLC
38,382US$101.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/29 09:59
End of Day Share Price 2026/01/27 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Repare Therapeutics Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Timothy ChiangCapital One Securities, Inc.
Hiroshi ShibutaniGoldman Sachs
null nullGuggenheim Securities, LLC